 25MG.jpeg)
Description
Jardiance 25 mg Tablet is an oral medication containing the active ingredient Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Manufactured by Boehringer Ingelheim and marketed in Bangladesh by Radiant Pharmaceuticals Ltd., Jardiance is primarily used to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise. Additionally, it has been shown to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
.jpeg)
 1GM.jpeg)
60 MG.jpeg)
 ..jpeg)
 10MG.jpeg)
 20MG.jpeg)
 ..jpeg)
 25MG.jpeg)
 2GM.jpeg)
Change Language